ABHI & OUH Symposium Portfolios

Oxford University Hospitals Foundation Trust (OUH) and Association of British HealthTech Industries (ABHI)

Symposium | 6 June 2022

1

Oxford University Hospitals NHS Foundation Trust is one of the largest acute teaching trusts in the UK, with a national and international reputation for the excellence of its services and its role in patient care, teaching and research.

The Trust supports world-leading research programmes in cardiovascular diseases, musculoskeletal disorders, neurological disorders such as Parkinson’s and Alzheimer’s through its designation as one of the UK’s five comprehensive biomedical centres. It works in close partnership with the University of Oxford and is a leading centre for cancer, neurosciences, diabetes, genetics and many other fields.

Research themes of particular strength are: cancer, cardiovascular science, diabetes, endocrinology and metabolism, infection and immunology, musculoskeletal science, neuroscience and reproduction and development.

This brings together academic research expertise with clinical teams to translate medical science into better healthcare treatments. Our patients benefit from world-class discovery and innovation supported by the NIHR Oxford Biomedical Research Centre, a partnership between the Trust and the University of Oxford, funded by the National Institute for Health Research.

The Trust employs over 12,000 staff and consists of four hospitals: the Churchill Hospital, John Radcliffe Hospital and Nuffield Orthopaedic Centre in Oxford and the Horton General Hospital in Banbury. On 1 October 2015 the Trust was awarded Foundation status and became Oxford University Hospitals NHS Foundation Trust.

About Association of British HealthTech Industries

ABHI supports the HealthTech community to provide products and services that help people live healthier lives.

As the voice of the industry, we show the value of health technology and overcome barriers to people benefitting from it now and in the future. ABHI have over 330 members who account for approximately 80% of the value of the sector in the UK, these members include leading multinationals through to small and medium sized enterprises.

We represent the HealthTech industry to key stakeholders, such as governments, healthcare systems and regulators.

2

Meet the Team

PETER ELLINGWORTH, Chief Executive Peter leads the Association of British HealthTech Industries (ABHI), the UK’s leading HealthTech trade association, representing 330 companies in MedTech, diagnostics and digital health. ABHI advocates industry’s needs at senior government level, supports UK market access, informs on commercial matters, provides regulatory advice, promotes ethical compliance and develops international trade opportunities for SMEs. Representing industry across government, Peter currently sits on the Secretary of State led Life Sciences Council, and the sector specific Health Technology Partnership which supports it. Peter also serves on the Trade Secretary's Life Sciences Trade Advisory Group, the Ministerial led Life Sciences Global Opportunities Board, the Life Sciences Scotland Industry Leadership Group and the advisory panel of Healthcare UK. A Board member of the Oxford AHSN, Peter leads work to enhance collaboration between ABHI members and the AHSN national network, most recently through the newly constituted MedTech Innovation National Network.

Peter chaired the Health Economy work stream of the London Health Commission that was established by the Mayor of London and Lord Ara Darzi. He is a former Board member of MedTech Europe, and the immediate past Chair of their National Association Network. He has also Chaired the Greater Manchester AHSN and previously sat on the advisory Board of Healthcare UK. From September 2022, Peter will also be a Health Executive in Residence at the UCL Global Business School for Health.

Peter has 35 years’ experience in sales, marketing and general management in the UK and across Europe and as a non-executive director of early stage companies. He is a proud member of the 30% Club, which campaigns for greater representation of women at senior leadership and board level, with a target of a minimum of 30%. Peter is also a GlobalScot - a worldwide network of business contacts who are experts in their field, and driven to help Scottish companies develop, expand and thrive in a competitive international market.

3

4

Tony Bowden, Chief Executive, Helicon Health

Tony is Chief Executive of Helicon Health. Having supported the company in a consultancy role in 2015, Tony was invited to take on the role of CEO and has overseen substantial growth in that period. Tony has over 30 years leadership experience in the Healthcare and Education technology sectors, during which time he founded and led two early- stage businesses in the UK and Europe and acted as Business Development Director for iSOFT and Computer Science Corporation Healthcare division.

Tony was previously a Partner and the Chairman at The IT Health Partnership, advising the NHS and suppliers to the NHS and private healthcare sectors in the drive towards joining up digital health and care. Tony is an angel investor in a number of high growth start-ups. He is passionate about supporting SMEs and promoting their role in driving economic growth and prosperity.

5

HUGO BREDA Managing Director, UK and Ireland Medical Devices, Johnson & Johnson

In 2019, Hugo Breda was appointed to Managing Director, JnJ Medical Devices for UK and Ireland where he has driven the organisation towards addressing the triple aim of improving patient outcomes and experience while reducing the total cost of care.

Most recently, Hugo served as JnJ Medical Devices EMEA Vice President responsible for leading the Strategic Capabilities department where he led the development of the services & solutions portfolio, CareAdvantage, as well as well as the EMEA wide responsibility for HEMA, pricing, SFE and BI. Hugo started his career in Nike as Strategic Account rep in Belgium and moved to Janssen 23 years ago. Advancing his career quickly with increasing responsibilities, Hugo went on to lead the Oncology, CNS, Immunology and General Medicine businesses in Janssen Austria & Switzerland and later moved to Paris for Janssen France where he had a strong track record of developing patient centric programs that create broader access to innovation and better outcomes for patients in Haematology, Schizophrenia, Alzheimer and Psoriasis.

Hugo holds a Master of Science in Physical Education and Kinesiology with a specialisation in coaching and training sciences from the university of Leuven.

6

ANDREW DAVIES Digital Health Lead ABHI Groups Andrew is responsible for working with partners to ensure that the UK maximises the opportunities for citizen health and economic wealth by appropriate investment in data driven healthcare.

A vital element of this is building on the unique opportunities delivered by the NHS to enable industry to access robust, well-curated data within a strong ethical framework.

Coupled with close engagement with national bodies to evolve regulatory and reimbursement systems, the aim is to create a strong infrastructure and commercial environment that can support the development and widespread adoption of the best HealthTech solutions.

Andrew has over 25 years' experience in the medical technology sector having worked within MedTech divisions of household names such as Thorn EMI, Philips and Bristol-Myers Squibb. He has held roles covering UK and international marketing, market access and business development across both capital and consumable equipment.

He has a degree in Applied Physics and a post graduate diploma in marketing.

7

ADAM M HILL, ABHI VICE CHAIR CEO Oncimmune Holdings PLC Adam is a dual-qualified Clinician and Mechanical Engineer with a career built at the interface of industry, academia and health systems. Over the last 2 decades he has trained in surgery in the British Army; founded a successful applied research centre at Imperial College London; provided growth strategy and investment advice to global life science companies on behalf of the British Government; led the global medical function of a multinational, publicly-listed health IT company; and pivoted a Formula One team into a developer of health technology. Currently, Adam is a Visiting Professor in Global Health Innovation at Imperial College London, sits on the Value Creation Committee of Imperial College Health Partners and is Non-Executive Director of Myrecovery.ai.

Adam graduated from Imperial College London as a Medical Doctor whilst also earning a PhD in Engineering, attending Imperial College Business School and the Royal Military Academy Sandhurst. He received his postgraduate clinical training from the Royal College of Surgeons of England, and professional engineering qualification from the Institution of Mechanical Engineers.

8

RICHARD PHILLIPS Director of Strategy ABHI Groups

Richard joined ABHI in June 2015 with over 20 years’ experience in the pharmaceutical and medical devices industries.

Richard holds a first degree in Sports Science from Brighton Polytechnic and a Master's in Health Economics Research and Management from Keele University. He served from 2003 until 2013 as a member of the Technology Appraisal Advisory Committee of the National Institute for Health and Care Excellence and also on the Programme Advisory Group of the Healthcare Quality and Information Authority in Ireland. Richard is a non-Executive Director of the West Midlands Academic Health Science Network, he sits on the Board of the Royal Orthopaedic Hospital, Birmingham and is the former Chair of the Small Business Research Initiative Programme Board. He is a longstanding member of the Institute of Healthcare Management.

Richard, his wife Luan, and their daughter Zelah Marie, live in North Birmingham and West Cornwall.

9

DUNCAN PORTER General Manager, Sample Collection & Transport, Thermo Fisher Scientific Duncan is the General Manger of the global Sample Collection and Transport Business of Thermo Fisher Scientific, leading the business strategy to enable streamlined sample to answer solutions to deliver earlier accurate diagnostics. He joined Thermo Fisher Scientific in 2018 as a Senior Marketing Director to lead the Clinical Microbiology category responsible for the global portfolio innovation including culture media, antibiotic susceptibility testing and most recently at the forefront of critical global pandemic programs including viral sample collection and serology antibody testing.

Duncan studied diagnostic radiography in Glasgow before starting his career with Fuji Film (UK). In 2002 he joined Royal Philips (NYSE: PHG, AEX: PHIA) a leading health technology company focused on improving people's health and well-being. Whilst at Philips, Duncan held numerous global leadership roles working and living in various countries around the world. This included setting up a Joint Venture in China and leading the diagnostic and interventional X-ray business in Asia Pacific and Japan. In 2010 Duncan completed his MBA from Warwick business school and has since lectured at both the Warwick Executive MBA program and the London School of Economics. In 2012 he returned to the UK as a member of the international leadership team responsible for the transition into medical devices with a focus on Cardiology and Peripheral Vascular disease.

10

NISHAN SUNTHARES Managing Director, Diagnostics Nishan Sunthares is Managing Director, Diagnostics.

He is responsible for leading ABHI's strategy to make high quality diagnostic technologies accessible to all who need them. ABHI’s focus on earlier detection and treatment of disease aligns with priorities of the NHS Long Term Plan and the potential for the enhanced use of HealthTech to deliver this is significant. He is an Executive Director of the ABHI Board.

In his time at ABHI Nishan has held a variety of roles including as Chief Operating Officer and has worked on commercial and market access policy issues relevant to the HealthTech industry. His regular, personal interaction with government Ministers, officials and NHS leaders has been key to increasing the Association’s impact. He has extensive knowledge of the HealthTech industry and health/government policy.

Nishan has worked in the health technology industry for 15+ years, and has held senior leadership roles in the industry across finance, marketing and commercial functions.

11

SIMON TALBOT, TREASURER (HONORARY ROLE) Managing Director, P3 Medical

Simon has over twenty years of experience in the medical device sector, ranging from multinational corporations through to start-up ventures. He has a financial background, being a chartered accountant, and has a particular interest in product development and innovation.

He founded P3, a Bristol-based company, and now serves as its Managing Director. Simon is also a Director of Medilink South West and Health Tech Hub at the University of the West of England.

12

JAMES URIE Sales & Marketing Director, Mediplus After graduation from university, where James studied Sports Science and Business Studies, James entered into a career involved in innovation and new technologies. Joining Mediplus in 2004, James has been involved in healthcare for more than 20 years.

As the Sales and Marketing Director at Mediplus James is responsible for delivering the overall global Sales and Marketing strategy as well as the internal and external marketing communications activities of the company. James is also responsible for the day-to-day management of the company's distribution partners in the Americas, Middle East and Australasian markets.

Initially starting as Product Manager, James successfully launched two new innovative Urology products. Both products are marketed throughout the Americas, mainland Europe and Australasia. James has successfully submitted these two products to the NHS Centre for Evidence Based Purchasing Department (CEP), National Horizons Scanning Centre, NHS National Technology Adoption Centre (NTAC), Department of Health Innovative Technology Adoption Procurement Programme (iTAPP). One of them received NICE Guidance in 2016.

Promoted to Marketing Manager in May 2006 and then Sales & Marketing Director in January 2007.

James is also a Fellow of The Chartered Institute of Marketing.

13

ANTOINE VALTERIO Country Manager UK/Ireland, ResMed Antoine is the Country Manager for ResMed’s UK and Ireland businesses responsible for transforming care pathways for Sleep and Chronic Respiratory Diseases with digital health solutions that deliver better patient outcomes. Previously he was Global Director of Marketing for ResMed’s Ventilation business. He joined ResMed in 2010 and has held a number of senior marketing and portfolio management positions across sleep, respiratory care and healthcare informatics with APAC and global remit.

Before joining ResMed, Antoine was the strategic advisor to the Chairman of the Board of Zuellig Pharma, Asia’s leading provider of distribution, digital and commercial services to the healthcare industry. Antoine has also served as the business development manager for a biotech SME driving profitable growth through international partnerships and market expansions. Earlier in his career, he spent a number of years in commercialization roles for Meat & Livestock Australia, a leading industry association helping members achieve greater competitiveness through commercial investments in innovation and technology.

Antoine holds an MBA from Curtin’s University of Technology, a Post Graduate Certificate in Business Enterprise from the University of Adelaide, and a Bachelor of Biotechnology Innovation (Honors) from the Queensland University of Technology.

14

PETER WORRALLO, Managing Director, Sales & Business Development, Penlon Limited Achievements        

30 years domestic UK and international medical device experience Developed and expanded the company’s global distribution channels Worked at all levels, multinationals, governments and B2B organisations.

Opened up China, Penlon were the first post-Gulf war Anaesthesia company into Iraq, Launched a series of new innovations in medication delivery and MRi. Winner of the Queens Award for Enterprise and for Innovation Member of the National Consortium providing COVID-19 ventilators to the NHS Experience M&A team member and Director.

ABHI Activities  

International Trade Group US Accelerator Programme

Having been employed in the medical device sector for most of my working life, I am now seeking an opportunity to pass on my 30 years international knowledge and experience. I hope to be able to positively contribute to the development of the ABHI and to assist the membership in their quest to deliver safe, compliant and innovative medical devices that serve to advance healthcare standards around the world. I believe that with my experience, I am well placed to build on the good work already undertaken by the ABHI. I am confident that working collaboratively with other members of the board, I can help develop and support the international trade agenda.

The UK medical device market is underpinned by a large number of small businesses seeking to develop, I have a keen interest in championing the SME agenda for ABHI. With the UK leaving the EU, the landscape for British companies manufacturing and selling medical devices is changing and I hope that with my experience in running an SME, I may be in a position to enhance the representation of this important sub-group. ABHI has an important role, working with industry and government as well as other domestic and international stakeholders, I have held senior management positions for a number of years and believe I can represent the association at any level.

15

NEIL HARRIS General Manager, Abbott I have been General Manager of Abbott’s diabetes care business in the UK and Ireland for three and a half years, I also chair the Abbott UK leadership team which includes heads of all UK commercial, corporate and manufacturing sites and functions, across nutrition, diagnostics and medical devices, who are responsible for over 2,500 staff. I have also chaired our Crisis Action Team throughout the current pandemic.

I’m fortunate to have developed a wide network of industry and policy-related contacts over the years. I am proud to have been an ABHI Board member since 2017 and one of the ABHI representatives on the Government’s Health Technology Partnership (HTP) group. This was established in early 2018 to drive engagement between the health tech industry and Ministers.

Two of my passions are people management and fostering the use of innovation. In terms of innovation, I have most recently led the successful introduction of Abbott’s FreeStyle Libre Glucose Monitoring system into the NHS. Before joining Abbott, I worked for Johnson & Johnson in various commercial roles for 11 years, leading business units focusing on general surgery and cardiovascular.

At the start of my commercial career, I worked at Ab-InBev for eight years, undertook various commercial roles with increasing responsibility, and therefore have extensive experience of the Fast-Moving Consumer Goods (FMCGs) sector.

16

Tim Clover CEO, Rayner Tim has spent 30 years in the international ophthalmic business with experience in medical devices, pharmaceuticals, services, digital healthcare and investment.

He was CEO of Moonray Healthcare a proprietary capital fund of Fidelity International investing in healthcare. Tim served as CEO and Chairman of several companies including Optegra, a chain of 23 specialist eye hospitals across Europe and Asia and Medvivo, a leading UK primary healthcare provider.

Tim was appointed to the Rayner board in 2014 and became CEO in 2015 to lead a strategic expansion plan. He successfully led an SBO by CVC Capital Partners in 2021 and during his tenure at Rayner, has concluded several acquisitions to expand and diversify the company into a global leader in eye care.

17

Phil Duffin, Commercial Excellence Manager, Arthrex.

I have worked in the Medical Device industry for 10+ years. My early career focused on Orthopedic Trauma in both Regional and National roles. From 2013 I have led and developed Commercial teams and strategies to cooperate with the evolving health system landscape in the UK. I am currently Commercial Excellence Manager with Arthrex Ltd, overseeing Commercial Sales, Customer Services, Capital Services, Business Insights and Pricing.

18

Robert Emery, Regional Director – South East Philips Health Systems

Rob is an approachable and experienced people leader, with a broad range of industry experience across Sales and Operations within the healthcare sector. He has a degree in International Business along with a Chartered Institute of Marketing Diploma. Rob has worked for Philips since 2004 where he has held a variety of roles including Service Director and his current role of Regional Director. Rob is also a Trustee at the College of Radiography.

19

Bettina Fitt, General Manager of Zimmer Biomet UK and Ireland

General Manager of Zimmer Biomet UK and Ireland since April 2022. Extensive experience in MedTech having held Senior Roles within Medtronic and GE Healthcare. Formerly Chair of AxRem, and on MMTSG. Trained as Nurse and Midwife.

Law Degree and Masters of Business

20

Dr Jonathan Gledhill, Head of Healthcare, Huma Therapeutics Jonathan has a PhD in Biochemistry and over 12 years' experience in senior management and commercial roles in healthcare and technology. He is responsible for developing Huma’s partnerships and collaborations with the NHS, and led Huma’s NHS COVID-19 virtual ward deployments and other remote patient monitoring implementations to help manage surgery waitlists and support those with long-term conditions.

Huma is a global digital health technology company headquartered in the UK that exists to help people live longer, fuller lives (London Tech Week 2021 video). Our highly configurable and award-winning platform supports virtual wards and remote patient monitoring (RPM) across different disease areas, and in life sciences we power some of the world’s largest decentralised clinical trials and studies. Huma's technology connects patients and clinicians through a smartphone patient app and a web-browser clinician portal. Care teams can remotely monitor patients, spot deterioration and deliver proactive care. Our platform is in use across 20+ NHS sites and other healthcare systems globally, including Germany, the Middle East and beyond. Huma's technology has been deployed to support elective recovery and the safe management of patients on cardiac and orthopaedic surgery waiting lists, to monitor people at home with COVID-19 / respiratory illness, and to support those with chronic diseases such as type 2 diabetes, heart disease and heart failure (BBC Feature).

Huma's RPM has been shown to almost double clinical capacity, reduce readmissions by >30%, enable 40% shorter length of stay and help spot deterioration in the ~10% of at-risk waitlist patients who needed surgery prioritised. These benefits sit alongside a 3-4 times lower mortality rate, market-leading patient experience (net promoter score +71) and ~90% adherence rate (NHSX Evaluation, BMC Primary Care, Open Forum Infectious Diseases, JAMIA Open and summary).

21

Kamaljit (Kam) Hunjan is Regional Managing Director of Olympus in the UK & Ireland.

Kamaljit (Kam) Hunjan is Regional Managing Director of Olympus in the UK & Ireland.

Olympus specialises in the development, manufacture and supply of medical equipment worldwide.

Kam joined Olympus in September 2020 as Regional Managing Director, having brought with him a strong track record in transformation and sustainable growth.

Prior to joining Olympus, Kam worked with the Movianto Group (subsidiary of Owens & Minor) where he led the business unit as Senior Vice President & Managing Director. Prior to that he was with Ceva Logistics as Senior Vice President & Global Healthcare Sector Head.

He assumed the sector responsibility and his primary objective was growth and business improvement. Kam also worked in General Electric Oil & Gas and Healthcare Business where he assumed executive roles in supply chain transformation.

Kam has lived and worked internationally and has a strong understanding of local/regional and global business environments.

Kam holds a BEng (Hons) in Production Systems, and MSc in Engineering Business Management from Warwick University.

22

Pamela Penn, NHS Executive Partnership Manager 3M Medical Solutions Division Pam moved to the UK from the US after university and has worked in healthcare supporting the NHS for the last 20 years. Pam started work creating homecare services for renal patients and then moved into pharmaceuticals where her passion for service redesign started. Pam’s work then shifted to healthcare technology supporting pathway redesign and clinically led innovation; delivering results for patients and financially within the NHS. Pam has been part of several start up’s in the UK delivering services that include remote vital sign monitoring, virtual wards and hospital at home programmes.

Pam is now part of the 3M leadership function within the NHS Executive Partnership team for the Medical Solutions Division. This team brings strategic focus to 3M Healthcare and aims to support the ICS structure and wider NHS. The team will deliver value and senior level expertise to the NHS through data analysis, bespoke education, pathway redesign and supporting clinical change. 3M are committed to delivering better, safer, smarter healthcare.

23

Nick Walker, Country Director, UK & Ireland Edwards Lifesciences Nick Walker is the Country Director, UK & Ireland, for Edwards Lifesciences, the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.

Nick is responsible for leading the UKI senior leadership team which includes commercial and functional heads that encompass sales, marketing, strategy, public affairs, finance, customer services, HR, quality and regulatory affairs. He is also responsible for the local government affairs strategy and has a focus on raising the political & public awareness of cardiovascular disease.

In 20+ years within the Medical Device industry, Nick has worked in Public Affairs, Corporate Strategy, Business Development & Finance and is a member of the ABHI Heart Valve Disease and Cardiovascular Disease Groups.

24

25

Rachel Trace General Manager, Baxter U.K and Ireland Rachel is the General Manager for Baxter in the UK and Ireland which is comprised of 3000 plus employees. Baxter’s therapeutic areas include acute renal, chronic renal, nutrition, medication delivery and pharmacy services. Rachel is responsible for leading the UKI senior leadership team which includes commercial and functional heads - sales, marketing, operations, manufacturing, quality, regulatory and tech service. Rachel is also responsible for Baxter’s strategic capabilities division - Integrated Care Solutions. A key focus of this division is to transform healthcare through partnerships that focus on improving health outcomes, quality of care as well as driving efficiency savings across different clinical pathways.

Rachel has over 20 years of experience in the medical devices and pharmaceutical sector.

Prior to Baxter she spent 15 years at Johnson and Johnson Medical Devices working in various different commercial roles to include general surgery, cardiovascular and in vitro diagnostics.

As a leader Rachel is passionate about diversity and inclusion and believes this sits at the foundation of innovation, driving value for both healthcare professionals, patients and industry.

Rachel has been an active member of ABHI sitting on a variety of different groups since 2014.

26

Daniel Jones, Government Affairs Director UK & Ireland Stryker

27

Bruno L Holthof, MD, PhD, MBA, Chief Executive Officer Oxford University Hospitals NHS Foundation Trust Appointed October 2015 Bruno Holthof is the Chief Executive Officer (CEO) of Oxford University Hospitals NHS Foundation Trust (OUH). OUH employs 12,000 staff across four hospital sites and 44 other locations.

Before OUH, he was CEO of the Antwerp Hospital Network from January 2004 until September 2015. During this period, he transformed ZNA into the most profitable hospital group in Belgium.

Before becoming a CEO, he was a partner at McKinsey & Company. During this period, he served a wide range of healthcare clients in Europe and the United States and gained significant expertise in the areas of strategy, organisation and operations.

28

He holds an MBA from the Harvard Business School and an MD/PhD from the University of Leuven.”

Professor Meghana Pandit, Chief Medical Officer Oxford University Hospitals NHS Foundation Trust Professional Qualifications: MBBS, FRCOG, MBA Experience: Meghana trained in Obstetrics & Gynaecology in the Oxford Deanery and was Visiting Lecturer in Urogynaecology at University of Michigan, Ann Arbor, USA. Meghana was Consultant Obstetrician and Gynaecologist, Clinical Director and then Divisional Director at Milton Keynes before joining University Hospitals Coventry and Warwickshire NHS Trust (UHCW) where Meghana was Chief Medical Officer from May 2012 to December 2018 and Deputy Chief Executive from 2014. Meghana completed MBA from Oxford Brookes University and the Innovating Health for Tomorrow Programme at INSEAD, Fontainebleau.

Meghana was awarded the Founding Senior Fellowship of the Faculty of Medical Management and Leadership and is Honorary Professor at Warwick University. Meghana is Associate Fellow at Green Templeton College, University of Oxford.

As Chief Medical Officer at UHCW, Meghana led the development of clinical strategy and had responsibility for Clinical Quality, Risk, Medical Education, Research & Development, and Legal Services. She was Responsible Officer for over 500 doctors and undertook clinical office based Gynaecology.

As Chief Medical Officer at Oxford University Hospitals, Meghana has responsibility for Clinical Safety and Outcomes, Infection Prevention & Control, Medical Education, and Research & Development. She is also Responsible Officer for over 1000 doctors. Meghana continues her association with Warwick University.

29

Jason Dorsett, Chief Finance Officer Oxford University Hospitals NHS Foundation Trust Appointed October 2016 Jason is the responsible executive at OUH responsible for Finance, Procurement, Planning & Contracting and Commercial. He is also the Chair of the South 4 NHS Pathology Network.

His interests include the application of innovation to solving real world healthcare problems and sponsoring projects to improve quality and efficiency through safer and more effective care.

Jason is a graduate of the University of Oxford, where he completed a doctorate in modern history. His extensive career experience includes serving as Deputy Finance Director at University College London Hospitals NHS Foundation Trust, and roles within NHS Improvement, HM Treasury and major audit and professional services companies.

30

Gary Welch, Director of Procurement and Supply Chain Oxford University Hospitals NHS Foundation Trust

Gary is the Director of Procurement and Supply Chain at Oxford University Hospitals NHS Foundation Trust.

After a career in engineering and production management in the oil/gas and chemical processing industries, Gary joined the NHS in 2005 as part of the Supply Chain Excellence Programme.

Gary was project manager for the one of the first collaborative procurement hubs in the NHS and then went on to be Programme Director for the development of the NHS London Procurement Programme where he was also Managing Director for 3 years.

Gary has since held a number of senior procurement roles at various Trusts across the NHS. He is an enthusiastic advocate of supplier innovation and is particularly interested in the potential for the procurement profession and suppliers to work more closely in supporting better patient care and increased efficiency and innovation in the delivery of healthcare.

Gary is a mechanical engineer (BEng) by training and holds an MBA from University of Durham Business School.

31

Dr Andrew Brent Consultant in Infectious Diseases & Medicine | Director of Clinical Improvement | Deputy Chief Medical Officer Oxford University Hospitals NHS Foundation Trust

Andrew Brent is a Consultant in Infectious Diseases and Medicine, Deputy Chief Medical Officer and Director of Clinical Improvement at Oxford University Hospitals NHS Foundation Trust. He chairs the Technologies Advisory Group (TAG) which reviews applications for all new technologies and procedures in the Trust. He has led and continues to support a number of Improvement and innovation initiatives in the Trust.

32

Ben Attwood FRCP FRCA FFICM PGDipLATHE Divisional Director CSS Division, Consultant, Intensive Care & Anaesthetics Oxford University Hospitals NHS Foundation Trust

Ben is an Critical Care and Anaesthetics consultant and Divisional Director for Clinical Support Service at OUH. He was appointed as a Clinical Trials Scholar to the NIHR West Midlands based at the Warwick Clinical Trials Unit.

He has a particular interest in technology as a tool for transformation in healthcare, and as Chief Clinical Informatics Officer at his previous trust clinically led their EPR procurement.

33

Rainer Bühler Divisional Director of Operations for the Surgery, Women’s and Oncology Division.

Oxford University Hospitals NHS Foundation Trust Mr Rainer Bühler is the Div. Director of Operations for the Surgery, Women’s and Oncology Division. He has contributed to and/or led the development of its services over the last 12 years.

Significant examples of achievements include for the Surgical Emergency Unit with a dedicated team of consultant surgeons, the establishment of a robotic surgical programme, since 2021 with a second Da Vinci Robot and driving the implementation of a paper-light/free model maximising the potential of the Cerner Millennium electronic patient record (EPR). He thrives working in a Division with close links to the academic departments at the University.

Other projects in recent years included the integration of a second hospice into the Oncology & Haematology Directorate or major reconfiguration of clinical services across the Churchill Hospital site, working closely multiple agency stakeholders incl PFI partner organisations. His track record working with surgical and non-surgical cancer services included a 6-month secondment as interim MD for the Thames Valley Cancer Alliance in 2020/21. He is committed in his role to support and facilitate all efforts to increase sustainability and reduce waste and has recently joined the Greener Theatres forum working across the OUH.

34

Alison Jackman Deputy Director of Strategic Sourcing Clinical & Medical Technology Oxford University Hospitals NHS Foundation Trust Leading a team of Procurement professionals who like OUH Clinical professionals – we hold the patient experience at the forefront of our sourcing activity and commercial decisions.

Alison joined OUH in September 2019 as Deputy Director, having brought with her a strong track record in Supplier relationship Management and Global Procurement and Supply Chain leadership.

Prior to joining the Trust, Alison worked within the eCOA industry (Signant Health) previously known as (CRF Health) where she led a Global Procurement and Supply Chain organisation with teams located in London, Kent (United Kingdom) Philadelphia and San Diego (USA) Prior to that Alison has enjoyed over twenty years’ experience within the Automotive industry as Director of Supply Chain. Alison has worked on large scale transformation projects delivering lean processes and operational improvement. Working for both OEM and Aftermarket organisations in the UK and for a period in Herentals, Antwerpen.

Alison holds a Supply Chain Diploma, accredited Prince 2, Six Sigma and is a Chartered Fellow of the Institute Logistics and Transport (FCILT)

35

Dr Paul Durrands, Chief Operating Officer Oxford AHSN

Paul joined the Oxford AHSN in 2013. He has oversight of all its activities with a particular focus on governance, business planning, environmental sustainability and partnerships with integrated care systems.

Paul has an extensive commercial background, with international experience of licensing, contracting and mergers and acquisitions. He has also been a director of two life sciences companies and an international food company.

36

Zahir Soonawalla, Consultant Surgeon Oxford University Hospitals NHS Foundation Trust Zahir Soonawalla is a Consultant Surgeon at Oxford University Hospitals. He leads the tertiary service for hepatobiliary and pancreatic disorders for Thames Valley. Last year he introduced robotic liver and pancreatic surgery and chairs the robotic steering committee at the Churchill Hospital. He has an interest in neuroendocrine tumours, works with UKINETs Clinical Practice Committee to develop national guidelines, and is involved with trialling a patient App. Zahir is Deputy Divisional Medical Director with a role in ensuring safe patient care. In this role his focus has been in improving productivity in theatres. Through the COVID pandemic he effectively steered the delivery of elective cancer surgery through challenging times. He is the Principal Investigator for several clinical trials at Oxford and is one of the six key NHS partners of the Pancreatic Cancer Research Fund Tissue Bank. He is presently on Council of the Association of Upper GI Surgeons.

37

38